d.barros
TL2 Moderator · Catania
Contributes reviews on supplier material. Based in Catania.
Joined 29 August 2025 · last posted 7d
77 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #63 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2026 · 9 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #56 · Practice › Side effects · 17 Jul 2026 · 12 likes Picking up post #53: that is the part I would want checked first. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some…
-
Reading a home test result without over-claiming Replied, post #122 · Analytics › Home & field testing · 16 Jul 2026 · 2 likes On post #118 — agreed on the reasoning, with one qualification. What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds…
-
Revisiting: The best-written scientific paper you have read Replied, post #91 · Lounge › Off topic · 14 Jul 2026 · 20 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #30 · Compounds › Repair & healing peptides · 14 Jul 2026 · 0 likes post #29 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Tracking a shortage from primary sources rather than rumour Replied, post #101 · Access › Shortages · 13 Jul 2026 · 0 likes This follows post #98 rather than contradicting it. Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding…
-
Pooling trials with different estimands Replied, post #85 · Evidence › Meta-analyses · 10 Jul 2026 · 6 likes Picking up post #82: that is the part I would want checked first. Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same…
-
Asking a follow-up: new topic or new reply? Replied, post #41 · Start Here › How to Ask · 7 Jul 2026 · 24 likes post #40 answers the question as asked. The question underneath it is different. The specific question in the title is more useful than you might think. A title like "a…
-
Designing a personal experiment that could change your mind — one year on Replied, post #68 · Research Methods › N-of-1 designs · 30 Jun 2026 · 6 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #21 · Access › Insurance & coverage · 15 Jun 2026 · 0 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
Racemisation and why it is invisible to a mass measurement Replied, post #92 · Analytics › Impurities & related substances · 13 Jun 2026 · 21 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #83 · Evidence › Journal club · 11 Jun 2026 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Micronutrient adequacy at low total intake Replied, post #52 · Nutrition & Training › Protein & intake · 10 Jun 2026 · 3 likes I read post #50 twice before replying, because I had assumed the opposite. Meeting protein targets on suppressed appetite: this is where the practical difficulty lies.…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #27 · Evidence › Journal club · 10 Jun 2026 · 0 likes Worth separating two things that post #23 runs together. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not…
-
Journal club: LEADER as the historical anchor Replied, post #83 · Evidence › Journal club · 2 Jun 2026 · 12 likes On post #79 — agreed on the reasoning, with one qualification. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective…
-
Labelling requirements for research chemicals — the long version Replied, post #2 · Sourcing › Regulatory · 25 May 2026 · 31 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Revisiting: What pooling buys you and what it destroys Replied, post #32 · Evidence › Meta-analyses · 24 May 2026 · 26 likes This follows post #29 rather than contradicting it. Publication bias: what did not get published? Small studies with negative results are less likely to be published…
-
Talking to a therapist about this specifically Replied, post #5 · Wellbeing › Mental health · 14 May 2026 · 13 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #19 · Analytics › COA interpretation · 1 May 2026 · 0 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
CJC-1295 with and without DAC: what the modification does Replied, post #46 · Compounds › Secretagogues & GH axis · 1 May 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: is percentage weight change the right endpoint? Replied, post #93 · Evidence › Journal club · 22 Apr 2026 · 22 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
List price versus negotiated price versus what you pay Replied, post #7 · Access › Pricing · 7 Apr 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #91 · Sourcing › Vendor reports · 7 Apr 2026 · 4 likes Picking up post #88: that is the part I would want checked first. Blind submission is worth the effort: have someone else relabel the sample so neither you nor the…
-
Citation sweep results: how many references did not say what was claimed Replied, post #72 · Meta › Wiki maintenance · 5 Apr 2026 · 29 likes Picking up post #69: that is the part I would want checked first. Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #31 · Evidence › Trials · 3 Apr 2026 · 5 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Prediction intervals and why they are more honest than confidence intervals Started this topic · Evidence › Meta-analyses · 30 Mar 2026 · 4 likes Posting this under the heading it deserves: Prediction intervals and why they are more honest than confidence intervals Everything below is what sits behind that.…
-
Personal import allowances, compared — a second dataset Replied, post #89 · Access › International · 21 Mar 2026 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Managing an unplanned gap in supply Replied, post #42 · Access › Shortages · 25 Feb 2026 · 4 likes post #41 is right about the mechanism and I think understates the practical bit. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
-
Measurement error in a self-reported exposure Replied, post #11 · Evidence › Study critique · 22 Feb 2026 · 0 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #110 · Analytics › Mass spectrometry · 15 Feb 2026 · 0 likes Worth separating two things that post #106 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
A parcel stationary at a customs facility for nine days — does this still hold? Started this topic · Sourcing › Logistics · 8 Jan 2026 · 43 likes The question in the title: A parcel stationary at a customs facility for nine days — does this still hold? I will give what I have already checked below so nobody…
-
Tracking a preprint to publication: a worked example Replied, post #131 · Evidence › Preprints · 13 Dec 2025 · 8 likes Worth separating two things that post #127 runs together. Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That…
-
Availability by country, dated, with primary sources — one year on Replied, post #6 · Access › International · 12 Dec 2025 · 32 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #9 · Compounds › Retatrutide · 21 Nov 2025 · 12 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
The headache that turns out to be dehydration Replied, post #56 · Nutrition & Training › Hydration & electrolytes · 14 Nov 2025 · 26 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
-
Lyophilisation and why the cake looks the way it does Replied, post #23 · Pharmacology › Formulation chemistry · 3 Nov 2025 · 3 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
-
New subcategory: rationale and scope Replied, post #127 · Meta › Announcements · 26 Oct 2025 · 2 likes I read post #125 twice before replying, because I had assumed the opposite. Feedback to announcements: if you have feedback on an announced change (not a question, but…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #97 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 28 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Tracking that stops updating and then resumes Replied, post #31 · Sourcing › Logistics · 29 Sep 2025 · 0 likes Coming back to post #29, because the follow-up matters more than the original answer. Packaging integrity on arrival: if a parcel arrives with compromised packaging,…
-
Substitution between formats during a shortage Replied, post #41 · Access › Shortages · 18 Aug 2025 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #25 · Start Here › Welcome · 13 Aug 2025 · 1 like Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #18 · Access › Pricing · 8 Aug 2025 · 30 likes Worth separating two things that post #14 runs together. International pricing: the same compound costs very different amounts in different countries because healthcare…
-
Comparing two chromatograms from different laboratories, properly Started this topic · Analytics › HPLC & UHPLC · 31 Jul 2025 · 59 likes Posting this under the heading it deserves: Comparing two chromatograms from different laboratories, properly Everything below is what sits behind that. I would like to…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #4 · Practice › Side effects · 24 Jul 2025 · 0 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #59 · Sourcing › Regulatory · 24 Jul 2025 · 9 likes On post #55 — agreed on the reasoning, with one qualification. Off-label use and medical practice: clinicians can prescribe approved medications off-label under some…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #69 · Compounds › Oral incretins · 23 Jul 2025 · 3 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Angle of injection and whether 90 degrees is always right Replied, post #3 · Practice › Administration · 21 Jul 2025 · 26 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Titles that describe the question, not the situation Replied, post #41 · Start Here › How to Ask · 4 Jul 2025 · 24 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #108 · Wellbeing › Mental health · 26 Jun 2025 · 0 likes post #107 answers the question as asked. The question underneath it is different. Sleep and mental health: these compounds can affect sleep for some people. Sleep…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #6 · Compounds › Semaglutide · 25 Jun 2025 · 12 likes Coming back to post #4, because the follow-up matters more than the original answer. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #121 · Access › Insurance & coverage · 15 Jun 2025 · 3 likes Coming back to post #119, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #19 · Data & Tools › Calculators · 6 Jun 2025 · 0 likes This follows post #16 rather than contradicting it. Precision and significant figures: the calculators do not round to match your input precision. If you input values…
-
Price changes over 2025 and 2026, tabulated and dated Replied, post #5 · Access › Pricing · 3 Jun 2025 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #19 · Compounds › Repair & healing peptides · 21 May 2025 · 0 likes post #18 is right about the mechanism and I think understates the practical bit. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5…
-
A well-designed study with a badly written abstract Replied, post #90 · Evidence › Study critique · 18 May 2025 · 21 likes On post #86 — agreed on the reasoning, with one qualification. Publication bias: a single published positive trial is weaker evidence than multiple published trials…
-
Washout: how long is long enough, and for what purpose Replied, post #21 · Pharmacology › Pharmacokinetics · 26 Apr 2025 · 7 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
A claim built entirely on a subgroup analysis Replied, post #6 · Evidence › Study critique · 25 Apr 2025 · 2 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Requesting a page: what makes a good request Replied, post #70 · Documentation › Wiki requests · 25 Apr 2025 · 0 likes post #69 is right about the mechanism and I think understates the practical bit. Cross-referencing: if you notice two pages that should reference each other but do not,…
-
Sequence verification for an obscure compound: how it is done Replied, post #15 · Compounds › Other compounds · 18 Apr 2025 · 12 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #17 · Access › Pricing · 17 Apr 2025 · 0 likes On post #13 — agreed on the reasoning, with one qualification. International pricing: the same compound costs very different amounts in different countries because…
-
A certificate with no method stated: what can you conclude? Replied, post #14 · Analytics › COA interpretation · 1 Apr 2025 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. When a document puts the specification in the result column, it has told you the release…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #46 · Access › Insurance & coverage · 27 Mar 2025 · 33 likes Coming back to post #44, because the follow-up matters more than the original answer. Coverage for weight management versus diabetes: many formularies cover these…
-
Adjudicated events and why the definition matters — the long version Replied, post #51 · Evidence › Trials · 17 Mar 2025 · 29 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Telehealth prescribing models in the US Replied, post #66 · Regional › North America · 4 Mar 2025 · 14 likes post #65 answers the question as asked. The question underneath it is different. Regional variation in North America: access differs substantially by US state and…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #26 · Documentation › Doc review · 18 Feb 2025 · 0 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #47 · Access › International · 16 Feb 2025 · 24 likes Picking up post #44: that is the part I would want checked first. Customs and import outcomes: different routes have different seizure rates. Some countries are…
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #5 · Practice › Administration · 4 Feb 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #49 · Evidence › Meta-analyses · 3 Feb 2025 · 1 like Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #2 · Clinical › Comorbidities · 16 Dec 2024 · 7 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Promotion criteria, and the one that stops most nominations Replied, post #131 · Documentation › Doc review · 4 Dec 2024 · 0 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
-
Two sessions a week versus four: what the evidence supports Replied, post #13 · Nutrition & Training › Resistance training · 24 Nov 2024 · 6 likes Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding. Expecting continuous progress during weight loss is unrealistic.
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #23 · Clinical › Special populations · 21 Nov 2024 · 24 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #10 · Sourcing › Red flags · 29 Oct 2024 · 13 likes On post #6 — agreed on the reasoning, with one qualification. Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #113 · Clinical › Comorbidities · 27 Oct 2024 · 12 likes post #112 is right about the mechanism and I think understates the practical bit. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT…
-
US compounding rules and how they changed Replied, post #11 · Regional › North America · 4 Oct 2024 · 30 likes Picking up post #8: that is the part I would want checked first. Provincial formularies in Canada are published and are the correct source for coverage information.…
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #2 · Evidence › Preprints · 20 Sep 2024 · 1 like the opening post is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive…
-
Converting between mg/mL and units per dose, both directions Replied, post #13 · Practice › Reconstitution · 7 Sep 2024 · 13 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…